Opening book details…
About this book
Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs by Lisa J. Alcock, Yunchao Chang, Jamie A. Jarusiewicz, Marisa Actis, Stanley Nithianantham, Anand Mayasundari, Jaeki Min, Dylan Maxwell, Jeremy Hunt, Brandon Smart, Jun J. Yang, Gisele Nishiguchi, Marcus Fischer, Charles G. Mullighan & Zoran Rankovic is a book available to read on EtoBox.
- Author
- Lisa J. Alcock, Yunchao Chang, Jamie A. Jarusiewicz, Marisa Actis, Stanley Nithianantham, Anand Mayasundari, Jaeki Min, Dylan Maxwell, Jeremy Hunt, Brandon Smart, Jun J. Yang, Gisele Nishiguchi, Marcus Fischer, Charles G. Mullighan & Zoran Rankovic
- Published
- 2022
- Language
- EN
More by Lisa J. Alcock, Yunchao Chang, Jamie A. Jarusiewicz, Marisa Actis, Stanley Nithianantham, Anand Mayasundari, Jaeki Min, Dylan Maxwell, Jeremy Hunt, Brandon Smart, Jun J. Yang, Gisele Nishiguchi, Marcus Fischer, Charles G. Mullighan & Zoran Rankovic
Similar books
- Covalent Modification of the JH2 Domain of Janus Kinase 2 — Sean P. Henry, Maria-Elena Liosi, Joseph A. Ippolito, Fabian Menges, Ana S. Newton, Joseph Schlessinger & William L. Jorgensen (2022)
- Discovery of Potent PROTACs for the Potential Treatment of Leukemia — Robert B. Kargbo (2022)
- Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist — Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, Hiromichi Sugimoto, Kei Masuda, Norio Ohyabu, Yoshihiro Banno, Norihito Tokunaga, Tetsuji Kawamoto, Yoshihide Tomata, Yasumi Kumagai, Motoo Iida, Yoichi Nagano, Mariko Yoneyama-Hirozane, Yuji... (2022)
- Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor — Brian J. Groendyke; Behnam Nabet; Mikaela L. Mohardt; Haisheng Zhang; Ke Peng; Eriko Koide; Calvin R. Coffey; Jianwei Che; David A. Scott; Adam J. Bass; Nathanael S. Gray (2021)
- Development of Highly Potent and Selective Pyrazolopyridine Inhibitor of CDK8/19 — John M. Hatcher, Prasanna S. Vatsan, Eric Wang, Jie Jiang & Nathanael S. Gray (2021)
- Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2 — Minh H. Nguyen, Onur Atasoylu, Liangxing Wu, Kanishk Kapilashrami, Michelle Pusey, Karen Gallagher, Cheng-Tsung Lai, Peng Zhao, Joseph Barbosa, Kai Liu, Chunhong He, Colin Zhang, Evan D. Styduhar, Michael R. Witten, Yaoyu Chen, Luping Lin, Yan-ou Yang,... (2022)